down arrow

Ligand Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US53220K5048
USD
188.50
-6.6 (-3.38%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
830.44
700.91
597.49
821.16
709.52
767.23
Shareholder's Funds
830.44
700.91
597.49
821.16
709.52
767.23
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
1.29
0.41
77.41
322.13
450.77
640.20
Secured Loans
1.29
0.41
77.41
322.13
450.77
640.20
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
32.45
31.41
22.09
-4.87
40.28
7.33
Other Long Term Liabilities
74.22
69.52
66.37
114.05
110.36
71.72
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
74.22
69.52
66.37
434.77
552.65
710.68
Current Liabilities
Trade Payables
5.23
2.43
5.31
8.40
3.78
2.42
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
37.11
16.78
98.81
41.66
100.11
17.00
Total Liabilities
941.77
787.22
762.67
1,297.59
1,362.29
1,494.91
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
33.07
31.72
37.62
39.02
41.98
20.39
Less: Accumulated Depreciation
8.27
6.66
10.12
6.42
4.81
2.85
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
24.81
25.06
27.49
32.60
37.17
17.54
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
21.49
48.32
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
6.92
5.92
4.74
272.03
4.27
2.36
Total Non-Current Assets
610.21
549.79
499.07
832.84
861.73
371.27
Current Assets Loans & Advances
Current Investments
183.86
147.35
166.86
321.59
363.57
998.32
Inventories
14.11
23.97
13.29
27.33
26.49
7.30
Sundry Debtors
38.38
32.92
30.42
85.45
56.85
30.39
Cash and Bank
72.31
22.95
45.01
19.52
47.96
72.27
Other Current Assets
312.73
233.59
260.20
460.08
497.08
1,119.64
Short Term Loans and Advances
4.07
6.39
4.61
6.19
2.22
11.36
Total Current Assets
331.56
237.43
263.60
464.75
500.56
1,123.64
Net Current Assets (Including Current Investments)
294.45
220.65
164.79
423.09
400.45
1,106.64
Total Current Assets Excluding Current Investments
331.56
237.43
263.60
464.75
500.56
1,123.64
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
941.77
787.22
762.67
1,297.59
1,362.29
1,494.91
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
1.29
0.41
77.41
322.13
450.77
640.20
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is 6.76% vs 4.75% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -1.00% vs -8.84% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is -55.53% vs 0.00% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 39.65% vs -9.93% in Dec 2023

Compare Balance Sheet Results of Ligand Pharmaceuticals, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
830.44
502.75
327.69
65.18%
Shareholder's Funds
830.44
502.75
327.69
65.18%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
1.29
0.01
1.28
12,800.00%
Secured Loans
1.29
0.01
1.28
12,800.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
32.45
0
32.45
0.00%
Other Long Term Liabilities
74.22
6.59
67.63
1,026.25%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
74.22
6.59
67.63
1,026.25%
Current Liabilities
Trade Payables
5.23
3.26
1.97
60.43%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
37.11
73.45
-36.34
-49.48%
Total Liabilities
941.77
582.79
358.98
61.60%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
33.07
0
33.07
0.00%
Less: Accumulated Depreciation
8.27
0
8.27
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
24.81
4.71
20.10
426.75%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
21.49
0
21.49
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
6.92
0.12
6.80
5,666.67%
Total Non-Current Assets
610.21
20.46
589.75
2,882.45%
Current Assets Loans & Advances
Current Investments
183.86
406.75
-222.89
-54.80%
Inventories
14.11
3.32
10.79
325.00%
Sundry Debtors
38.38
13.88
24.50
176.51%
Cash and Bank
72.31
124.97
-52.66
-42.14%
Other Current Assets
312.73
548.92
-236.19
-43.03%
Short Term Loans and Advances
4.07
0
4.07
0.00%
Total Current Assets
331.56
562.33
-230.77
-41.04%
Net Current Assets (Including Current Investments)
294.45
488.88
-194.43
-39.77%
Total Current Assets Excluding Current Investments
331.56
562.33
-230.77
-41.04%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
941.77
582.79
358.98
61.60%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
1.29
0.01
1.28
12,800.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 0.00 Million
in Dec 2024

Figures in Million
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 74.22 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.76% vs 4.75% in Dec 2023

Annual - Fixed Assets
Fixed Assets 24.81 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -1.00% vs -8.84% in Dec 2023

Annual - Investments
Investments 21.49 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -55.53% vs 0.00% in Dec 2023

Annual - Current Assets
Current Assets 331.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 39.65% vs -9.93% in Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."